News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
VASCONCELLES MICHAEL
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/03/2023 |
4
| VASCONCELLES MICHAEL (EVP R&D & MEDICAL AFFAIRS) has filed a Form 4 on ImmunoGen, Inc.|
Txns:
| Granted 960,000 options to buy
@ $5.16, valued at
$5M
|
|
| 01/03/2023 |
3
| VASCONCELLES MICHAEL (EVP R&D & MEDICAL AFFAIRS) has filed a Form 3 on ImmunoGen, Inc. |
| 08/17/2022 |
4
| VASCONCELLES MICHAEL (Director) has filed a Form 4 on Magenta Therapeutics, Inc.|
Txns:
| Granted 40,000 options to buy
@ $1.77, valued at
$70.8k
|
|
| 08/17/2022 |
3
| VASCONCELLES MICHAEL (Director) has filed a Form 3 on Magenta Therapeutics, Inc. |
| 04/11/2019 |
4
| VASCONCELLES MICHAEL (Chief Medical Officer) has filed a Form 4 on Unum Therapeutics Inc.|
Txns:
| Granted 61,900 options to buy
@ $4.36, valued at
$269.9k
|
|
| 03/28/2018 |
3
| VASCONCELLES MICHAEL (Chief Medical Officer) has filed a Form 3 on Unum Therapeutics, Inc. |
|
|